ESPR insider buying and SEC filings, explained
Esperion Therapeutics, Inc. · CIK 1434868
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$576K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 17, 2026 | Sale | Benjamin Looker (Chief Legal Officer) sold 11,824 shares at $3.16 ($37K). Holdings down 2% to 667,524 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 17, 2026 | Sale | Sheldon L. Koenig (CEO and Director) sold 53,588 shares at $3.16 ($169K). Holdings down 2% to 2,119,111 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Jun 17, 2026 | Sale | Benjamin Halladay (CFO) sold 10,773 shares at $3.16 ($34K). Holdings down 2% to 702,829 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 18, 2026 |
| Mar 17, 2026 | Sale | Benjamin Looker (Chief Legal Officer) sold 5,708 shares at $2.70 ($15K). Holdings down 1% to 679,348 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Mar 17, 2026 | Sale | Sheldon L. Koenig (CEO and Director) sold 25,578 shares at $2.72 ($70K). Holdings down 1% to 2,172,699 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Mar 17, 2026 | Sale | Benjamin Halladay (CFO) sold 6,424 shares at $2.71 ($17K). Holdings down 1% to 713,602 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 18, 2026 |
| Jan 20, 2026 | Sale | Benjamin Looker (General Counsel) sold 1,689 shares at $2.88 ($5K). Holdings down <1% to 384,216 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 21, 2026 |
| Dec 17, 2025 | Sale | Sheldon L. Koenig (CEO and Director) sold 48,244 shares at $3.67 ($177K). Holdings down 3% to 1,470,587 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Sale | Benjamin Halladay (CFO) sold 7,337 shares at $3.67 ($27K). Holdings down 2% to 467,525 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 17, 2025 | Sale | Benjamin Looker (General Counsel) sold 6,517 shares at $3.67 ($24K). Holdings down 2% to 385,905 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
18 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow ESPR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.